We are in the process of putting together the CP/AACP Psychiatry Update 2021 program.
Please SIGN UP for email updates to keep informed of program developments for our upcoming conference as they become available.
Jointly provided by Postgraduate Institute for Medicine and Global Academy for Medical Education. The American Board of Psychiatry and Neurology has reviewed the Current Psychiatry/AACP 2020 Psychiatry Update and has approved this program as part of a comprehensive CME program, which is mandated by the ABPN as a necessary component of maintenance of certification (MOC). The activity awards 23 AMA PRA Category 1 Credits™ (including post-conference workshops) and 8 Self-Assessment Category 1 CME credits.
This activity is intended for pediatric, general and geriatric psychiatrists, nurse practitioners, physician assistants, nurses, psychologists, social workers and other mental health professionals engaged in the care of patients with ADHD, Alzheimer’s Disease, Women’s Mental Health, Depression, Psychosis, Hallucinations, Adult and Pediatric Anxiety and Mood Disorders, College Mental Health, Addiction, Geriatric Psychiatry, Insomnia and Sleep Disorders, and Personality Disorder.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education:
July 15, 2020 – July 23, 2020 - The Postgraduate Institute for Medicine designates this live activity for a maximum of 23 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
July 6, 2020 - November 1, 2020 - The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 23 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education:
The maximum number of hours awarded for this Continuing Nursing Education activity is 23 contact hours. Pharmacotherapy contact hours (4.2 credits for the main conference and 2 APRN credits for the Addiction workshop and 1 APRN credit for the Cannabis workshop) for Advance Practice Registered Nurses will be indicated on your certificate.
At the conclusion of this activity, participants should be able to:
- Recognize overlapping symptoms and devise an approach to address the individual patient’s comorbidities
- Diagnose and treat multiple psychiatric disorders
- Demonstrate a working knowledge of medication combinations and adjunctive therapies with the best evidence of efficacy to integrate practice guidelines for their treatment
- Utilize pharmacotherapy and non-pharmacotherapy in the treatment of ADHD, depression, anxiety, schizophrenia and psychotic episodes, hallucinations, postpartum and other women’s mental health disorders, insomnia and sleep disorders, mood, borderline personality, Alzheimer’s disease and long-term care issues